Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-069018

Director acquired 2,057 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PATOU GARY Director 2021-12-08 Option exercise +2,057 $3.67 $7,549 25,630 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
PATOU GARY Director 2021-12-08 Option exercise · Stock Option (Right to Buy) −2,057 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…